Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 91
Titolo Data di pubblicazione Autore(i) File
Prognostic value of FDG uptake by the bone marrow in squamous cell carcinoma of the head and neck 1-gen-2008 Cicone, F.; Loose, D.; Deron, P.; Vermeersch, H.; Signore, A.; Van de Vyvere, F.; Scopinaro, F.; Van de Wiele, C.
Studying the metabolic activity of red bone marrow by means of FDG-PET: The need for a standardization 1-gen-2008 Cicone, F.; Signore, A.; Scopinaro, F.
Radioimmunotherapy of heavily pre-treated, non-Hodgkin's lymphoma patients: efficacy and safety in a routine setting 1-gen-2009 Cicone, Francesco; Baldini, Rossella; Cox, Maria Christina; Russo, Eleonora; Torelli, Fabio; Tofani, Anna; Scopinaro, Francesco
Tc-99m DTPA cisternography shows disappearance of cerebrospinal fluid leakage after standing a short time 1-gen-2009 Del Mastro, Carolina; Cicone, Francesco; D'Andrea, Giancarlo; Scopinaro, Francesco
Visual and quantitative approach to bone marrow foci of increased glucose uptake on PET/CT in a case of aplastic anaemia 1-gen-2010 Cicone, F.; Stalder, M.; Geiger, D.; Cairoli, A.; Bischof Delaloye, A.; Prior, J. O.
A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with 90Y-ibritumomab tiuxetan (Zevalin) 1-gen-2010 Pacilio, M.; Betti, M.; Cicone, F.; Del Mastro, C.; Montani, L.; Chiacchiararelli, L.; Monaco, A.; Santini, E.; Scopinaro, F.
Follicular lymphoma at relapse after rituximab containing regimens: Comparison of time to event intervals prior to and after 90Y-ibritumomab-tiuxetan 1-gen-2011 Cicone, F.; Russo, E.; Carpaneto, A.; Prior, J. O.; Delaloye, A. B.; Scopinaro, F.; Ketterer, N.
Rituximab-like radiolabelled antibodies for the treatment of non-hodgkin's lymphomas 1-gen-2012 Cicone, F.; Scopinaro, F.
Fatal pulmonary tumour thrombotic microangiopathy: do typical FDG-PET findings exist? 1-gen-2012 Cicone, F; Del Forno, M; Papa, A; Comito, F; Festa, A; Uccini, S; Scopinaro, F
Three-dimensional patient-specific dosimetry in radioimmunotherapy with 90Y-ibritumomab-tiuxetan 1-gen-2012 D'Arienzo, M.; Cicone, F.; Chiacchiararelli, L.; Coniglio, A.; Delaloye, A. B.; Scopinaro, F.
Anatomical substrates of cognitive and clinical dimensions in first episode schizophrenia 1-gen-2013 Rigucci, S.; Rossi-Espagnet, C.; Ferracuti, S.; De Carolis, A.; Corigliano, V.; Carducci, F.; Mancinelli, I.; Cicone, F.; Tatarelli, R.; Bozzao, A.; Girardi, P.; Comparelli, A.
Quantification of dose nonuniformities by voxel-based dosimetry in patients receiving 90Y-ibritumomab-tiuxetan 1-gen-2013 Cicone, F.; D'Arienzo, M.; Carpaneto, A.; Russo, E.; Coniglio, A.; Bischof Delaloye, A.; Scopinaro, F.
Malignant Lymphoma in Children 1-gen-2014 Cicone, Francesco; Uccini, Stefania
Imaging the future: A report from the Young Daily EANM Forum 2013 1-gen-2014 Cicone, F.; Jamar, F.; Zerizer, I.
ROLE OF 18F-DOPA PET/CT IN NON-ENHANCING GLIOMAS 1-gen-2014 Scaringi, C; Cicone, F; Papa, A; Scopinaro, F; Minniti, G; Maurizi Enrici, R
F-DOPA PET identifies high tumor grade and anaplastic transformation in non-enhancing gliomas 1-gen-2014 Cicone, F; Scaringi, C; Papa, A; Maurizi Enrici, R; Minniti, G; Scopinaro, F
The importance of standardizing acquisition settings and interpretation criteria of radionuclide cisternography 1-gen-2014 Cicone, F.; Mastro, C. D.; Scopinaro, F.
Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI 1-gen-2015 Cicone, F.; Filss, C. P.; Minniti, G.; Rossi-Espagnet, C.; Papa, A.; Scaringi, C.; Galldiks, N.; Bozzao, A.; Shah, N. J.; Scopinaro, F.; Langen, K. -J.
Thyro-gastric autoimmunity in patients with differentiated thyroid cancer: a prospective study 1-gen-2015 Cicone, F.; Papa, A.; Lauri, C.; Tofani, A.; Virili, C.; Centanni, M.; Scopinaro, F.; Annibale, B.
Why not consider PET/CT in the workup of pulmonary tumour thrombotic microangiopathy? 1-gen-2015 Cicone, F.; Abe, K.
Mostrati risultati da 1 a 20 di 91
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile